Cyclin-dependent kinase 4/6 inhibitors (CDK4/6i) combined with endocrine therapy (ET) are the standard first-line treatment for hormone receptor-positive (HR+), human epidermal growth factor receptor ...
Amanda Kalinsky, 30, of Nashville, learned four years ago that she has a genetic mutation that causes Gertsmann-Straussler-Scheinker Disease, or GSS, a rare neurodegenerative condition that causes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback